Artificial Intelligence In Genomics Market by Offering (Software, Services),Technology (Machine Learning, Computer Vision), Functionality (Genome Sequencing, Gene Editing), Application (Diagnostics), End User (Pharma, Research) & Region - Global Forecasts to 2025
The global Artificial Intelligence In Genomics Market boasts a total value of $202 million in 2020 and is projected to register a growth rate of 52.7% to reach a value of $1,671 million by 2025. The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.
To know about the assumptions considered for the study, download the pdf brochure
AI in Genomics Market Growth Dynamics
Growth Drivers: Need to control the time and cost of drug discovery and development
Drug discovery is a very costly and lengthy process, owing to which there is a need for alternative tools in discovering new drugs. Drug discovery and development is commonly conducted through in vivo and in vitro methods, which are very costly and time-consuming.
Growth Opportunities: focus on developing human-aware AI systems
The aim of developing AI technologies was to make them human-aware or capable of human thinking patterns. However, creating interactive and scalable machines remains a challenge for the developers of AI machines.
Restraints: Lack of skilled AI workforce and ambiguous regulatory guidelinesFor medical software Healthcare Fraud
An AI is a complex system; to develop, manage, and implement AI systems, companies require a workforce with certain skill sets. For instance, personnel dealing with AI systems should be aware of cognitive computing, ML and machine intelligence, deep learning, and image recognition. Integrating AI solutionsinto existing systems is also a challenging task requiring extensive data processing to replicate humanbrain behavior. Even a minor error can result in system failure or adversely affect the desired result.
Challenges: Laack of curated genomics data
Data is a vital source to train and develop a complete and robust AI system. Earlier, datasets were mostlystructured and entered manually. However, the growing digital footprint and technology adoption, such as IoT in healthcare and life science, has resulted in large data volumes that are unstructured (and in theform of text, voice, or images)
Pharmaceutical & biotechnology companies accounted for the largest market share
Based on the end user, the AI in genomics market is broadly segmented into pharmaceutical biotechnology companies; healthcare providers; research centers, academic institutes, & governmentorganizations; and other end users. Pharmaceutical & biotechnology companies accounted for the largestshare of the end-user market in 2019. Market growth can be attributed to the rising demand for solutions to cut the time and costs of drug development..
North America accounted for the largest share of the global AI in genomics market
In 2019, North America accounted for the largest share of the market, followed by Europe. The large share of North America can be attributed to the increasing research funding and government initiatives for promoting precision medicine in the US.
Some of the key players include IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK), Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), and Engine Biosciences Pte. Ltd. (US).
Scope of the AI in genomics market Report
|
Report Metrics |
Details |
|
Market Size value 2025 |
USD 1671 million |
|
Growth Rate |
52.7% Compound Annual Growth Rate (CAGR) |
|
Largest Market |
North America |
|
Market Dynamics |
Drivers, Opportunities, Restraints & Challenges |
|
Largest Share Segments |
|
|
Table of Content |
|
|
Market Segmentation |
Offering, Offering, Functionality, End User And Regional. |
|
AI in genomics markett Growth Drivers |
Need to control the time and cost of drug discovery and development |
|
AI in genomics market Growth Opportunities |
Focus on developing human-aware AI systems |
|
Report Highlights |
|
|
Geographies Covered |
North America, Europe, APAC, MEA, and Latin America |
This research report categorizes the AI in genomics market into the following segments:
By Offering
- Software
- Services
By Technology
-
Machine Learning
- Deep Learning
- Supervised Learning
- Reinforcement Learning
- Unsupervised Learning
- Other Machine LearningnTechnologies
- Other Technologies
By Functionality
- Genome Sequencing
- Gene Editing
- Clinical Workflows
- Predictive Genetic Testing & Preventive Medicine
By Application
- Diagnostics
- Drug Discovery & Development
- Precision Medicine
- Agriculture & animal Research
- Other Applications
By end user
- Pharmaceutical & Biotech Companies
- Healthcare Providers
- Research Centers, Academic Institutes, &
- Government Organizations
- Other End Users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Rest of Europe
- Asia Pacific
- Rest of the World
Recent Developments:
- In February 2020, IBM Watson Health signed partnership with Broad Institute of MIT and Harvard (US). An extended partnership will allow the Broad Institute to analyze and explore genomics data to understand intrinsic susceptibility.
- In October 2020, NVIDIA announced a partnership with global healthcare company GSK and its AI group. GSK’s new hub in London is expected to support its UK based team and scientists from NVIDIA to enhance drug and vaccine discovery using NVIDIA platforms..
Frequently Asked Questions (FAQ):
What is the size of AI In Genomics Market ?
The AI In Genomics Market size is projected to reach USD 1,671 Million by 2025, growing at a CAGR of 52.7%.
What are the major growth factors of AI In Genomics Market ?
The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.
Who all are the prominent players of AI In Genomics Market ?
Prominent players in the market are IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK),Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), Engine Biosciences Pte. Ltd. (US)
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 23)
1.1 OBJECTIVES OF THE STUDY
1.2 AI IN GENOMICS MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 ARTIFICIAL INTELLIGENCE IN GENOMICS: MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 27)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.2 SECONDARY SOURCES
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 PRIMARY SOURCES
2.3.2 BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY DEMAND SIDE, SUPPLY SIDE, DESIGNATION, AND REGION
2.3.2.1 Key industry insights
2.4 AI IN GENOMICS MARKET SIZE ESTIMATION
FIGURE 1 BOTTOM-UP APPROACH
FIGURE 2 TOP-DOWN APPROACH
FIGURE 3 ESTIMATION OF THE MARKET SIZE THROUGH THE ADOPTION-BASED APPROACH
TABLE 1 FACTOR ANALYSIS
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 4 DATA TRIANGULATION METHODOLOGY
2.6 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 37)
FIGURE 5 AI IN GENOMICS MARKET, BY OFFERING, 2020 VS. 2025 (USD MILLION)
FIGURE 6 MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
FIGURE 7 MARKET, BY FUNCTIONALITY, 2020 VS. 2025 (USD MILLION)
FIGURE 8 MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 9 MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE MARKET
4 PREMIUM INSIGHTS (Page No. - 41)
4.1 AI IN GENOMICS: MARKET OVERVIEW
FIGURE 11 INCREASING PUBLIC AND PRIVATE INVESTMENTS IN AI IN GENOMICS AND ADOPTION OF AI SOLUTIONS FOR PRECISION MEDICINE ARE DRIVING MARKET GROWTH
4.2 MARKET, BY END USER
FIGURE 12 PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
4.3 NORTH AMERICA: MARKET, BY TECHNOLOGY & COUNTRY (2019)
FIGURE 13 US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019
4.4 GEOGRAPHICAL SNAPSHOT OF THE MARKET
FIGURE 14 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 44)
5.1 INTRODUCTION
5.2 AI IN GENOMICS MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Need to control the time and costs of drug development and discovery
5.2.1.2 Increasing investments in AI in genomics
5.2.1.3 Rising adoption of AI in precision medicine
5.2.1.4 Growing genomic datasets
5.2.2 RESTRAINTS
5.2.2.1 Lack of skilled AI workforce and ambiguous regulatory guidelines for medical software
5.2.3 OPPORTUNITIES
5.2.3.1 Focus on developing human-aware AI systems
5.2.4 CHALLENGES
5.2.4.1 Lack of curated genomic data
5.2.4.2 Data privacy concerns
5.3 IMPACT OF COVID-19 ON THE MARKET
FIGURE 15 IMPACT OF COVID-19 ON THE MARKET
5.4 ECOSYSTEM
FIGURE 16 MARKET: ECOSYSTEM
6 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY OFFERING (Page No. - 51)
6.1 INTRODUCTION
TABLE 2 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY OFFERING, 2018–2025 (USD MILLION)
6.2 SOFTWARE
6.2.1 BENEFITS OFFERED BY SOFTWARE & STRONG DEMAND AMONG END USERS ARE DRIVING MARKET GROWTH
TABLE 3 MARKET FOR SOFTWARE, BY REGION, 2018–2025 (USD MILLION)
TABLE 4 NORTH AMERICA: MARKET FOR SOFTWARE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 5 EUROPE: MARKET FOR SOFTWARE, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 SERVICES
6.3.1 SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
TABLE 6 MARKET FOR SERVICES, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 NORTH AMERICA: MARKET FOR SERVICES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 8 EUROPE: MARKET FOR SERVICES, BY COUNTRY, 2018–2025 (USD MILLION)
7 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY TECHNOLOGY (Page No. - 56)
7.1 INTRODUCTION
TABLE 9 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
7.2 MACHINE LEARNING
TABLE 10 MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION)
TABLE 11 MARKET FOR MACHINE LEARNING, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 NORTH AMERICA: MARKET FOR MACHINE LEARNING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 13 EUROPE: MARKET FOR MACHINE LEARNING, BY COUNTRY, 2018–2025 (USD MILLION)
7.2.1 DEEP LEARNING
7.2.1.1 Deep learning is the fastest-growing and largest subsegment of machine learning
TABLE 14 MARKET FOR DEEP LEARNING, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: MARKET FOR DEEP LEARNING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 EUROPE: MARKET FOR DEEP LEARNING, BY COUNTRY, 2018–2025 (USD MILLION)
7.2.2 SUPERVISED LEARNING
7.2.2.1 Supervised learning can help create predictive models
TABLE 17 MARKET FOR SUPERVISED LEARNING, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 NORTH AMERICA: MARKET FOR SUPERVISED LEARNING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 EUROPE: MARKET FOR SUPERVISED LEARNING, BY COUNTRY, 2018–2025 (USD MILLION)
7.2.3 REINFORCEMENT LEARNING
7.2.3.1 APAC to show the highest growth in the reinforcement learning market
TABLE 20 MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 NORTH AMERICA: MARKET FOR REINFORCEMENT LEARNING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 EUROPE: MARKET FOR REINFORCEMENT LEARNING, BY COUNTRY, 2018–2025 (USD MILLION)
7.2.4 UNSUPERVISED LEARNING
7.2.4.1 Unsupervised learning algorithms allow for complex processing tasks, exceeding the capabilities of supervised systems
TABLE 23 MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2018–2025 (USD MILLION)
TABLE 24 NORTH AMERICA: MARKET FOR UNSUPERVISED LEARNING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 25 EUROPE: MARKET FOR UNSUPERVISED LEARNING, BY COUNTRY, 2018–2025 (USD MILLION)
7.2.5 OTHER MACHINE LEARNING TECHNOLOGIES
TABLE 26 MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 27 NORTH AMERICA: MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 EUROPE: MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)
7.3 OTHER TECHNOLOGIES
TABLE 29 MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 30 NORTH AMERICA: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 EUROPE: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)
8 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY FUNCTIONALITY (Page No. - 67)
8.1 INTRODUCTION
TABLE 32 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
8.2 GENOME SEQUENCING
8.2.1 GENOME SEQUENCING HOLDS THE LARGEST SHARE OF THE MARKET, BY FUNCTIONALITY
TABLE 33 MARKET FOR GENOME SEQUENCING, BY REGION, 2018–2025 (USD MILLION)
TABLE 34 NORTH AMERICA: MARKET FOR GENOME SEQUENCING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 35 EUROPE: MARKET FOR GENOME SEQUENCING, BY COUNTRY, 2018–2025 (USD MILLION)
8.3 GENE EDITING
8.3.1 GROWING IMPLEMENTATION OF MACHINE LEARNING IN GENE EDITING MAY HELP REDUCE TIME AND COSTS
TABLE 36 MARKET FOR GENE EDITING, BY REGION, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: MARKET FOR GENE EDITING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 EUROPE: MARKET FOR GENE EDITING, BY COUNTRY, 2018–2025 (USD MILLION)
8.4 CLINICAL WORKFLOWS
8.4.1 MACHINE LEARNING CAN HELP INCREASE THE EFFICIENCY OF THE CLINICAL WORKFLOW
TABLE 39 MARKET FOR CLINICAL WORKFLOW, BY REGION, 2018–2025 (USD MILLION)
TABLE 40 NORTH AMERICA: MARKET FOR CLINICAL WORKFLOW, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 41 EUROPE: MARKET FOR CLINICAL WORKFLOW, BY COUNTRY, 2018–2025 (USD MILLION)
8.5 PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE
8.5.1 AI IN GENOMICS CAN PREDICT OUTCOMES AND THE RISKS ASSOCIATED IN CURING GENETIC DISEASES, BASED ON THE AVAILABLE DATA
TABLE 42 MARKET FOR PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY REGION, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: MARKET FOR PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 EUROPE: MARKET FOR PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY COUNTRY, 2018–2025 (USD MILLION)
9 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY APPLICATION (Page No. - 74)
9.1 INTRODUCTION
TABLE 45 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
9.2 DIAGNOSTICS
9.2.1 DIAGNOSTICS FORMS THE LARGEST AND FASTEST-GROWING APPLICATION SEGMENT OF THE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET
TABLE 46 MARKET FOR DIAGNOSTICS, BY REGION, 2018–2025 (USD MILLION)
TABLE 47 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: MARKET FOR DIAGNOSTICS, BY COUNTRY, 2018–2025 (USD MILLION)
9.3 DRUG DISCOVERY & DEVELOPMENT
9.3.1 GROWING APPLICATION OF AI IN GENOMICS IN DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET GROWTH
TABLE 49 INDICATIVE LIST OF DEVELOPMENTS
TABLE 50 MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018–2025 (USD MILLION)
TABLE 51 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 52 EUROPE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018–2025 (USD MILLION)
9.4 PRECISION MEDICINE
9.4.1 PRECISION MEDICINE FOCUSES ON IDENTIFYING THE MOST EFFECTIVE MEDICAL TREATMENTS FOR PATIENTS
TABLE 53 INDICATIVE LIST OF DEVELOPMENTS FOR PRECISION MEDICINE APPLICATION
TABLE 54 MARKET FOR PRECISION MEDICINE, BY REGION, 2018–2025 (USD MILLION)
TABLE 55 NORTH AMERICA: MARKET FOR PRECISION MEDICINE,BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 56 EUROPE: MARKET FOR PRECISION MEDICINE, BY COUNTRY, 2018–2025 (USD MILLION)
9.5 AGRICULTURE & ANIMAL RESEARCH
9.5.1 AI IN GENOMICS HELPS IN IMPROVING THE PRODUCTIVITY OF CROPS AND LIVESTOCK
TABLE 57 MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018–2025 (USD MILLION)
TABLE 58 NORTH AMERICA: MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 59 EUROPE: MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
9.6 OTHER APPLICATIONS
TABLE 60 MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 61 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 62 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
10 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY END USER (Page No. - 84)
10.1 INTRODUCTION
TABLE 63 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.2.1 RISING DEMAND FOR SOLUTIONS TO CUT TIME AND COSTS OF DRUG DEVELOPMENT HAVE DRAWN END-USER ATTENTION TO AI IN GENOMICS
TABLE 64 INDICATIVE LIST OF DEVELOPMENTS
TABLE 65 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 66 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 67 EUROPE: ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
10.3 RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS
10.3.1 RISING RESEARCH ACTIVITY TO DRIVE THE USAGE OF AI IN GENOMICS SYSTEMS AMONG ACADEMIC & GOVERNMENT INSTITUTES
TABLE 68 INDICATIVE LIST OF RESEARCH COLLABORATIONS
TABLE 69 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 70 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 71 EUROPE: ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
10.4 HEALTHCARE PROVIDERS
10.4.1 INCREASING DEMAND FOR PHARMACOGENOMICS TO DRIVE THE ACCEPTANCE OF NGS IN HOSPITALS
TABLE 72 MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 73 NORTH AMERICA: MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 74 EUROPE: MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2018–2025 (USD MILLION)
10.5 OTHER END USERS
TABLE 75 MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 76 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 77 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
11 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY REGION (Page No. - 92)
11.1 INTRODUCTION
TABLE 78 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY REGION, 2018–2025 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 17 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SNAPSHOT
TABLE 79 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 80 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY OFFERING, 2018–2025 (USD MILLION)
TABLE 81 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 82 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION)
TABLE 83 NORTH AMERICA: MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
TABLE 84 NORTH AMERICA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 85 NORTH AMERICA: MARKET, BY END USER, 2018–2025 (USD MILLION)
11.2.1 US
11.2.1.1 The US dominates the North American AI in genomics market
TABLE 86 US: INDICATIVE LIST OF STRATEGIC DEVELOPMENTS
TABLE 87 US: MARKET, BY OFFERING, 2018–2025 (USD MILLION)
TABLE 88 US: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 89 US: MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 US: MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
TABLE 91 US: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 92 US: MARKET, BY END USER, 2018–2025 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Increasing research in genomics to drive market growth
TABLE 93 CANADA: MARKET, BY OFFERING, 2018–2025 (USD MILLION)
TABLE 94 CANADA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 95 CANADA: MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION)
TABLE 96 CANADA: MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
TABLE 97 CANADA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 98 CANADA: MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3 EUROPE
TABLE 99 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 100 EUROPE: MARKET, BY OFFERING, 2018–2025 (USD MILLION)
TABLE 101 EUROPE: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 102 EUROPE: MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 EUROPE: MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
TABLE 104 EUROPE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 105 EUROPE: MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.1 UK
11.3.1.1 UK to register the highest CAGR in the European market during the forecast period
TABLE 106 UK: MARKET, BY OFFERING, 2018–2025 (USD MILLION)
TABLE 107 UK: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 108 UK: MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 UK: MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
TABLE 110 UK: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 111 UK: MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Availability of funding for AI initiatives to boost the market growth in Germany
TABLE 112 GERMANY: MARKET, BY OFFERING, 2018–2025 (USD MILLION)
TABLE 113 GERMANY: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 114 GERMANY: MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION)
TABLE 115 GERMANY: MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
TABLE 116 GERMANY: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 117 GERMANY: MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Increasing government investments in genomics to boost the growth of the French market
TABLE 118 FRANCE: MARKET, BY OFFERING, 2018–2025 (USD MILLION)
TABLE 119 FRANCE: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 120 FRANCE: MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 FRANCE: MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
TABLE 122 FRANCE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 123 FRANCE: MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.4 ROE
TABLE 124 ROE: MARKET, BY OFFERING, 2018–2025 (USD MILLION)
TABLE 125 ROE: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 126 ROE: MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 ROE: MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
TABLE 128 ROE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 129 ROE: MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4 ASIA PACIFIC
11.4.1 EFFORTS TO DEVELOP IT INFRASTRUCTURE WILL DRIVE THE MARKET FOR AI IN THE APAC
FIGURE 18 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 130 ASIA PACIFIC: MARKET, BY OFFERING, 2018–2025 (USD MILLION)
TABLE 131 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 132 ASIA PACIFIC: MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 ASIA PACIFIC: MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
TABLE 134 ASIA PACIFIC: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 135 ASIA PACIFIC: MARKET, BY END USER, 2018–2025 (USD MILLION)
11.5 ROW
TABLE 136 ROW: MARKET, BY OFFERING, 2018–2025 (USD MILLION)
TABLE 137 ROW: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 138 ROW: MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION)
TABLE 139 ROW: MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
TABLE 140 ROW: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 141 ROW: MARKET, BY END USER, 2018–2025 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 122)
12.1 OVERVIEW
FIGURE 19 KEY DEVELOPMENTS IN THE MARKET (2018–2020)
12.2 MARKET: RANKING ANALYSIS (2019)
FIGURE 20 MARKET RANKING ANALYSIS, 2019
12.3 COMPETITIVE SCENARIO (2018–2020)
12.3.1 KEY AGREEMENTS, CONTRACTS, AND PARTNERSHIPS (2018–2020)
12.3.2 KEY PRODUCT LAUNCHES (2018–2020)
12.3.3 KEY EXPANSIONS (2018–2020)
12.3.4 KEY ACQUISITIONS (2018–2020)
12.4 COMPETITIVE LEADERSHIP MAPPING
12.5 VENDOR INCLUSION CRITERIA
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 EMERGING COMPANIES
FIGURE 21 AI IN GENOMICS: COMPETITIVE LEADERSHIP MAPPING, 2019
13 COMPANY PROFILES (Page No. - 127)
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 IBM
FIGURE 22 IBM: COMPANY SNAPSHOT (2019)
13.2 NVIDIA
FIGURE 23 NVIDIA: COMPANY SNAPSHOT (2019)
13.3 MICROSOFT CORPORATION
FIGURE 24 MICROSOFT CORPORATION: COMPANY SNAPSHOT (2020)
13.4 DEEP GENOMICS
13.5 BENEVOLENTAI
13.6 FABRIC GENOMICS
13.7 VERGE GENOMICS
13.8 FREENOME HOLDINGS
13.9 MOLECULARMATCH
13.10 CAMBRIDGE CANCER GENOMICS
13.11 SOPHIA GENETICS
13.12 DATA4CURE
13.13 PRECISIONLIFE
13.14 GENOOX
13.15 LIFEBIT
13.16 DIPLOID
13.17 FDNA
13.18 DNANEXUS
13.19 EMPIRIC LOGIC
13.20 ENGINE BIOSCIENCES
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
14 APPENDIX (Page No. - 149)
14.1 DISCUSSION GUIDE
14.2 AVAILABLE CUSTOMIZATIONS
14.3 RELATED REPORTS
14.4 AUTHOR DETAILS
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the blood collection devices market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary sources referred to for this research study include publications from government sources, such as WHO, PhRMA, AAAI and OECD. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global AI in genomics market, which was validated through primary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global AI in genomics market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Individual Physicians, Physician Groups, Hospitals, Clinics and Other Healthcare Facilities, pharmaceutical and biotechnology, Other End Users- Employer Groups and Government Bodies) and supply-side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, and Rest of the World. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
AI In Genomics Market Size Estimation
The global size of the market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the global market and other adjucent submarkets. The research methodology and the market numbers were then validated from primaries.
Data Triangulation
After arriving at the overall market size, from the market size estimation process explained above, the AI in genomics market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the market
Report Objectives
- To define, describe, segment, and forecast the global market based on offering, technology, functionality, application, end user and region
- To provide detailed information about the factors influencing market growth, such as drivers, opportunities, restraints and challenges
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall in AI in genomics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, the Asia Pacific (APAC), and RoW
- To profile the key players in the global market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments, such as product launches, expansions, acquisition and partnerships in the global market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Company information
- Detailed analysis and profiling of additional market players (up to 5)
Growth opportunities and latent adjacency in Artificial Intelligence In Genomics Market